US FDA approves Perrigo's contraceptive pill for over-the-counter use (updated)

Perrigo

13/07/2023 13:43

(Adds details from FDA statement throughout)
       July 13 (Reuters) - The U.S. Food and Drug
Administration on Thursday approved the over-the-counter use of
Perrigo's  PRGO.N  contraceptive drug, making it the first
non-prescription birth control pill in the United States. 
    The availability of Opill without prescription could allow
people to obtain an oral contraceptive without the need to first
see a health care provider, the FDA said.  
    The timeline for availability and price is determined by the
manufacturer, the FDA said. Perrigo did not immediately respond
to a Reuters request for comment on pricing.
    Contraceptives have been in focus since the U.S. Supreme
Court last year overturned the constitutional right to terminate
pregnancies as it scrapped a landmark ruling in the 1973 Roe vs.
Wade case.

 (Reporting by Manas Mishra in Bengaluru; Editing by Arun
Koyyur)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manaswrites15;))